Medicinal Mushrooms:
The Clinical Evidence
Medicinal mushrooms are among the most evidence-supported botanical therapies in integrative oncology. PSK from Trametes versicolor (Turkey Tail) is approved as an adjuvant cancer treatment in Japan, with RCT evidence for improved survival in gastric, colorectal, and breast cancer. Beta-glucan compounds from several species demonstrate consistent immunomodulatory effects in human trials.
Why Medicinal Mushrooms in Cancer Care?
Medicinal mushrooms have been used in traditional East Asian medicine for over 2,000 years. Modern pharmacological research has identified the active compounds responsible for their therapeutic effects — primarily beta-glucan polysaccharides, triterpenes, and lectins. These compounds interact with the innate and adaptive immune systems in ways that are directly relevant to cancer care: enhancing anti-tumour immunity, reducing treatment-related fatigue, and improving quality of life.
Unlike many complementary therapies, several medicinal mushroom preparations have been through rigorous clinical trials and are approved as adjuvant cancer treatments in Japan. Dr Kloppenburg incorporates medicinal mushroom therapy into integrative oncology plans where the evidence supports it and where it is safe alongside the patient's conventional treatment.
Evidence by Species
| Mushroom Species | Key Compounds | Evidence Level |
|---|---|---|
| Trametes versicolor (Turkey Tail) | PSK, PSP | Strong; RCTs; approved adjuvant in Japan |
| Lentinula edodes (Shiitake) | Lentinan, AHCC | Strong; RCTs; approved adjuvant in Japan |
| Ganoderma lucidum (Reishi) | Polysaccharides, triterpenes | Moderate; quality of life in cancer patients |
| Hericium erinaceus (Lion's Mane) | Hericenones, erinacines | Emerging; NGF stimulation; cognitive function |
| Inonotus obliquus (Chaga) | Betulinic acid, polysaccharides | Emerging; antioxidant; anti-inflammatory |
How Beta-Glucans Support Immune Function
Dectin-1 Receptor Activation
Fungal beta-glucans bind to Dectin-1 receptors on macrophages and dendritic cells, triggering innate immune activation and downstream adaptive immune responses.
NK Cell Stimulation
Beta-glucan supplementation has been shown in multiple human trials to increase natural killer (NK) cell activity, which is central to anti-tumour immune surveillance.
Cytokine Modulation
Medicinal mushroom extracts modulate pro- and anti-inflammatory cytokines, reducing chronic inflammation while maintaining anti-tumour immune activity.
Gut Microbiome Support
Beta-glucans act as prebiotics, supporting the gut microbiome — increasingly recognised as central to systemic immune function and treatment response in cancer.
Frequently Asked Questions
What is the evidence for medicinal mushrooms in cancer care?
The strongest evidence for medicinal mushrooms in cancer care is for polysaccharide extracts from Trametes versicolor (Turkey Tail) and Lentinula edodes (Shiitake). PSK (polysaccharide-K) from Turkey Tail is approved as an adjuvant cancer treatment in Japan and has evidence from multiple randomised controlled trials for improving survival in gastric, colorectal, and breast cancer.
What are beta-glucans and how do they work?
Beta-glucans are polysaccharides found in the cell walls of fungi. Fungal beta-glucans are recognised by pattern recognition receptors on immune cells (particularly Dectin-1 receptors on macrophages and dendritic cells), triggering innate immune activation. This leads to increased natural killer (NK) cell activity, enhanced macrophage function, and modulation of adaptive immunity.
Are medicinal mushroom supplements safe?
Medicinal mushroom supplements are generally well-tolerated with a good safety profile. The main safety considerations are quality and standardisation of the product, potential interactions with immunosuppressant medications, and the importance of using appropriate species and preparations. Dr Kloppenburg assesses medicinal mushroom therapy as part of a comprehensive integrative oncology consultation.
Which medicinal mushrooms have the best evidence?
The medicinal mushrooms with the strongest clinical evidence are: Trametes versicolor (Turkey Tail) — PSK approved in Japan for cancer; Lentinula edodes (Shiitake) — Lentinan approved in Japan; Ganoderma lucidum (Reishi) — evidence for quality of life in cancer patients; Hericium erinaceus (Lion's Mane) — evidence for cognitive function and nerve growth factor stimulation.
Discuss Medicinal Mushrooms With Dr Kloppenburg
Book a 60-minute remote consultation to review the evidence and assess which medicinal mushroom preparations are appropriate for your situation.
Remote consultations · UK-wide · 60 minutes · Book via call or online request